tirzepatide vs glp-1 Semaglutide | Understanding The Differences Tirzepatide vs semaglutide for weight

Vascular and systemic inflammation accelerate small-vessel disease, blood-brain barrier injury, and neuroinflammation all implicated in cognitive decline

Few believes potential GLP-1-induced skin changes are significant and common enough that they could lead to a new subspecialty among surgeons: I think we're going to find that the skin doesn't behave exactly the same, which means there's going to be a real question of, Is that skin more likely to have complications

Clinical Trial Results Phase 2 trial (published 2023): Patients lost an average of ~25% of their body weight at 48 weeks

Diabetic lumbosacral radiculoplexus neuropathy: a postmortem studied patient and review of the literature